Citigroup’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
17,405
+16,810
+2,825% +$365K ﹤0.01% 3841
2025
Q4
$15.6K Sell
595
-4,238
-88% -$110K ﹤0.01% 4930
2025
Q3
$109K Sell
4,833
-10,447
-68% -$215K ﹤0.01% 4236
2025
Q2
$304K Sell
15,280
-14,452
-49% -$282K ﹤0.01% 3870
2025
Q1
$502K Sell
29,732
-6,735
-18% -$115K ﹤0.01% 3676
2024
Q4
$674K Buy
36,467
+3,375
+10% +$65.9K ﹤0.01% 3624
2024
Q3
$719K Buy
33,092
+10,236
+45% +$229K ﹤0.01% 3503
2024
Q2
$448K Buy
22,856
+2,173
+11% +$45.4K ﹤0.01% 3467
2024
Q1
$449K Buy
20,683
+6,406
+45% +$159K ﹤0.01% 3645
2023
Q4
$413K Buy
14,277
+4,739
+50% +$127K ﹤0.01% 3544
2023
Q3
$255K Sell
9,538
-6,418
-40% -$219K ﹤0.01% 3528
2023
Q2
$591K Buy
15,956
+5,103
+47% +$178K ﹤0.01% 3250
2023
Q1
$339K Sell
10,853
-4,856
-31% -$156K ﹤0.01% 3411
2022
Q4
$468K Buy
15,709
+4,847
+45% +$173K ﹤0.01% 3224
2022
Q3
$414K Buy
10,862
+610
+6% +$30.6K ﹤0.01% 3371
2022
Q2
$559K Sell
10,252
-9,900
-49% -$544K ﹤0.01% 3127
2022
Q1
$1.26M Buy
20,152
+702
+4% +$46.2K ﹤0.01% 2741
2021
Q4
$1.96M Buy
19,450
+606
+3% +$53.3K ﹤0.01% 2639
2021
Q3
$1.7M Buy
18,844
+366
+2% +$33.3K ﹤0.01% 2673
2021
Q2
$1.7M Buy
18,478
+16,960
+1,117% +$1.35M ﹤0.01% 2783
2021
Q1
$147K Sell
1,518
-1,774
-54% -$183K ﹤0.01% 4186
2020
Q4
$172K Buy
3,292
+2,827
+608% +$118K ﹤0.01% 5097
2020
Q3
$19K Sell
465
-872
-65% -$27.3K ﹤0.01% 6229
2020
Q2
$21K Sell
1,337
-523
-28% -$8.01K ﹤0.01% 6569
2020
Q1
$20K Buy
1,860
+912
+96% +$12.7K ﹤0.01% 6686
2019
Q4
$12K Buy
+948
New +$11.3K ﹤0.01% 7137
2017
Q2
Sell
-171
Closed -$2K 7377
2017
Q1
$2K Sell
171
-22,709
-99% -$268K ﹤0.01% 6991
2016
Q4
$265K Buy
+22,880
New +$216K ﹤0.01% 5042

Other funds holding FLGT